PeptideStack
5.2kquestions
20kanswers
220users

All questions

Newest first. 5.2k questions across 107 tags.

5.2k questions · page 209 of 217

35 votes 5 answers34k views
What does 98.8% purity on a wide-pore C18 column actually tell me about a GLP-1 receptor agonist vial?

The particulars: 98.8% · a wide-pore C18 column · a GLP-1 receptor agonist. I want to understand what this actually establishes, as opposed to what it is being used…

hplc
hplc

Reverse-phase high-performance liquid chromatography, the workhorse purity method. Column chemistry, mobile-phase choice, gradient slope,…

503 questions
purity
purity

Purity as chromatographic area per cent - the fraction of detected material that is your target peak. It says nothing about how much material is…

833 questions
coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

771 questions
asked by pk_curve 30k · 2.3 years ago
18 votes0 answers13k views
How does retatrutide at 12 mg weekly compare on cost per milligram across routes?

Stated plainly: retatrutide · 12 mg. I have worked this out and I would like someone to find the error, because I suspect there is one. My working so far, for the…

cost-analysis
cost-analysis

Cost arithmetic done honestly: cost per milligram after dead-space loss, list versus net price, comparing a multi-dose vial to a fixed-dose pen,…

260 questions
vendor-comparison
vendor-comparison

Side-by-side comparison of suppliers on measurable axes - independently confirmed purity and content, lead time, cold-chain handling,…

388 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

764 questions
retatrutide
retatrutide

An investigational GLP-1, GIP and glucagon receptor tri-agonist, studied in the TRIUMPH programme. Not approved anywhere. Use this tag for…

251 questions
asked by ben_akintola 10k · 2.3 years ago
15 votes 5 answers38k views
Would you accept 98.4% on a GLP-1 receptor agonist from CPC without a content assay?

What I am working with: 98.4% · a GLP-1 receptor agonist · CPC. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not…

purity
purity

Purity as chromatographic area per cent - the fraction of detected material that is your target peak. It says nothing about how much material is…

833 questions
content-assay
content-assay

Quantified content: how many milligrams of peptide are actually in the vial, measured against a calibrated reference standard. A separate test…

476 questions
vendor-vetting
vendor-vetting

Evaluating a supplier on evidence rather than reputation: testing history across batches, whether certificates are batch-specific, how failures…

454 questions
asked by linnea_wahlberg 17k · 2.3 years ago
31 votes 5 answers55k views
Is 96.8% a realistic purity ceiling for mazdutide given its chain length?

Setup, so nobody has to ask: 96.8% · mazdutide. I have worked this out and I would like someone to find the error, because I suspect there is one. My working so far,…

purity
purity

Purity as chromatographic area per cent - the fraction of detected material that is your target peak. It says nothing about how much material is…

833 questions
hplc
hplc

Reverse-phase high-performance liquid chromatography, the workhorse purity method. Column chemistry, mobile-phase choice, gradient slope,…

503 questions
peptide-mapping
peptide-mapping

Enzymatic digestion followed by LC-MS/MS to confirm sequence rather than just mass. The method that catches a scrambled sequence or a D-amino-acid…

103 questions
mazdutide
mazdutide

A GLP-1 and glucagon receptor dual agonist developed primarily in China, with a distinct dose range and a fast-moving publication record.…

237 questions
asked by dmitri_savchuk 27k · 2.3 years ago
23 votes0 answers35k views
How do I get 8 units out of a vial reconstituted to 3.33 mg/mL without guessing?

What I am working with: 8 units · 3.33 mg/mL. This is a procedural question rather than a theoretical one, and I would like the procedure rather than the theory. What…

insulin-syringe
insulin-syringe

U-100 and U-40 insulin syringes as measuring instruments. A U-100 syringe is graduated in insulin units where 100 units equals 1 mL, so one unit…

244 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

764 questions
diluent-volume
diluent-volume

Choosing how much diluent to add, which is really a question about what you want your measurement resolution to be. Larger volumes buy you…

295 questions
asked by rukhsana_iqbal 17k · 2.3 years ago
27 votes 5 answers47k views
How do I compare WXT and WWB on lead time to South Africa?

What I am working with: WXT · WWB · South Africa. Both of these get recommended confidently by different people, which suggests neither is obviously right. My…

vendor-comparison
vendor-comparison

Side-by-side comparison of suppliers on measurable axes - independently confirmed purity and content, lead time, cold-chain handling,…

388 questions
international-shipping
international-shipping

Cross-border movement of research material: transit lanes and their thermal profiles, tracked versus untracked, declaration accuracy, and what…

471 questions
cold-chain
cold-chain

Keeping material within a temperature window from manufacture to use: phase-change packs versus dry ice, thermal mass, transit-lane temperature…

578 questions
asked by kofi_mensah 18k · 2.3 years ago
20 votes0 answers19k views
Is LDL-C worth drawing at baseline before starting a GLP-1 receptor agonist?

Setup, so nobody has to ask: LDL-C · a GLP-1 receptor agonist. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not…

bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

296 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questions
a1c
a1c

Glycated haemoglobin as a ninety-day glycaemic average: what a change of half a point means, why it lags, and the conditions under which it…

122 questions
lipids
lipids

Lipid response on treatment: triglycerides, LDL-C, non-HDL-C, ApoB and Lp(a), which of them move with weight loss, and why a fasting panel drawn…

139 questions
asked by thermal_mass 13k · 2.3 years ago
34 votes0 answers29k views
Is ESSENCE a fair comparison of a GLP-1 receptor agonist against its comparator arm?

Setup, so nobody has to ask: ESSENCE · a GLP-1 receptor agonist. This is asserted often enough that I assumed it was established, and then I went looking for the…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
semaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

470 questions
tirzepatide
tirzepatide

A dual GIP and GLP-1 receptor agonist. Questions here cover the SURPASS and SURMOUNT programmes, the practical differences from a pure GLP-1…

370 questions
asked by shear_at_the_front 17k · 2.3 years ago
30 votes 5 answers49k views
How much of the first four weeks of loss is fluid?

I am training twice a week and would rather optimise that than add a third session. I can do the algebra. I am not confident about the conversion factors. If there is…

plateau
plateau

A stall in progress: distinguishing adaptive thermogenesis from measurement error from adherence drift, how long to observe before changing…

36 questions
hydration
hydration

Fluid intake when thirst and intake cues are both blunted: how much of the early scale drop is fluid, how dehydration confounds a renal panel, and…

14 questions
weight-regain
weight-regain

Regain after stopping or reducing: the trajectory reported in the withdrawal extensions, how much is fluid, and what the maintenance arms tell us…

10 questions
asked by m_haraldsen 21k · 2.3 years ago
28 votes 5 answers31k views
Is ApoB worth drawing at baseline before starting retatrutide?

For reference: ApoB · retatrutide. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work…

bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

296 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questions
a1c
a1c

Glycated haemoglobin as a ninety-day glycaemic average: what a change of half a point means, why it lags, and the conditions under which it…

122 questions
lipids
lipids

Lipid response on treatment: triglycerides, LDL-C, non-HDL-C, ApoB and Lp(a), which of them move with weight loss, and why a fasting panel drawn…

139 questions
retatrutide
retatrutide

An investigational GLP-1, GIP and glucagon receptor tri-agonist, studied in the TRIUMPH programme. Not approved anywhere. Use this tag for…

251 questions
asked by cold_lane 10k · 2.3 years ago
17 votes 5 answers28k views
Is there any published stability data for cagrilintide at 37 °C?

What I have: cagrilintide · 37 °C. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am interested…

peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questions
storage
storage

Storage conditions and their evidence base: minus twenty degrees for powder, refrigerated for solution, protection from light, and what the…

701 questions
clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
amylin
amylin

Amylin and its analogues, most prominently cagrilintide, as a satiety mechanism orthogonal to incretin signalling. Includes the pharmacology of…

237 questions
asked by elke_brunner 17k · 2.3 years ago
41 votes 4 answers39k views
Would you re-test a GLP-1 receptor agonist after sixteen weeks at 30 °C, or accept the original certificate?

What I have: a GLP-1 receptor agonist · sixteen weeks · 30 °C. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone…

batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

910 questions
peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questions
coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

771 questions
asked by Dr_Priya_Raghunathan 49k · 2.3 years ago
34 votes0 answers46k views
Does headache at week six of dulaglutide usually resolve without a dose change?

Concretely: headache · six · dulaglutide. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have already made one mistake…

titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questions
dulaglutide
dulaglutide

A once-weekly GLP-1 receptor agonist built on an Fc fusion rather than fatty-acid acylation. Use this tag for questions about the fusion-protein…

200 questions
asked by carys_meredith 12k · 2.3 years ago
25 votes 5 answers52k views
When does hair thinning stop being a tolerability issue and become a clinical one?

I am comparing three suppliers on documentation rather than on price. I want to decide this in advance so that I am not deciding it under pressure later. Assume I…

harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questions
hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
pancreatitis
pancreatitis

Acute pancreatitis as a labelled risk: background incidence, the signal in pooled trial and pharmacovigilance data, lipase interpretation, and the…

30 questions
asked by hana_petrikova 10k · 2.3 years ago
40 votes 5 answers23k views
How comparable are semaglutide and liraglutide on the evidence available?

For reference: semaglutide · liraglutide. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know that, so I can…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
semaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

470 questions
tirzepatide
tirzepatide

A dual GIP and GLP-1 receptor agonist. Questions here cover the SURPASS and SURMOUNT programmes, the practical differences from a pure GLP-1…

370 questions
liraglutide
liraglutide

A once-daily GLP-1 receptor agonist and the compound that established the class. Still relevant for its shorter half-life, its paediatric and…

235 questions
asked by siobhan_deasy 9.5k · 2.3 years ago
36 votes4 answers67k views
Is 37 °C an acceptable storage condition for lyophilised liraglutide?

Conditions: 37 °C · liraglutide. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and monographs without…

storage
storage

Storage conditions and their evidence base: minus twenty degrees for powder, refrigerated for solution, protection from light, and what the…

701 questions
peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questions
shelf-life
shelf-life

How long a preparation remains within specification: labelled expiry for a sealed lyophilised vial, beyond-use dating after reconstitution, and…

327 questions
liraglutide
liraglutide

A once-daily GLP-1 receptor agonist and the compound that established the class. Still relevant for its shorter half-life, its paediatric and…

235 questions
asked by bridget_nyathi 12k · 2.3 years ago
20 votes 5 answers35k views
Why does oxidation accelerate at 2–8 °C rather than proceeding linearly?

Concretely: oxidation · 2–8 °C. This is one of those things that everyone repeats and nobody derives. This matters practically, not just academically, because it…

peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questions
storage
storage

Storage conditions and their evidence base: minus twenty degrees for powder, refrigerated for solution, protection from light, and what the…

701 questions
hplc
hplc

Reverse-phase high-performance liquid chromatography, the workhorse purity method. Column chemistry, mobile-phase choice, gradient slope,…

503 questions
asked by s_bhattacharya 31k · 2.3 years ago
40 votes 4 answers68k views
Does survodutide adsorb measurably to the vial wall at 20 mg/mL?

The case in front of me: survodutide · 20 mg/mL. I want the working, not the result — I need to be able to redo it with different numbers. I care about the precision…

peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questions
content-assay
content-assay

Quantified content: how many milligrams of peptide are actually in the vial, measured against a calibrated reference standard. A separate test…

476 questions
storage
storage

Storage conditions and their evidence base: minus twenty degrees for powder, refrigerated for solution, protection from light, and what the…

701 questions
survodutide
survodutide

A GLP-1 and glucagon receptor dual agonist with a substantial published MASH dataset. Use this tag for its hepatic endpoints, its dose ladder, and…

225 questions
asked by mg_per_ml 15k · 2.3 years ago
25 votes0 answers33k views
Does headache at week six of orforglipron usually resolve without a dose change?

The particulars: headache · six · orforglipron. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have already made one…

titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questions
orforglipron
orforglipron

A non-peptide, orally bioavailable small-molecule GLP-1 receptor agonist studied in the ATTAIN programme. It is not a peptide, which changes…

219 questions
asked by ben_akintola 10k · 2.3 years ago
27 votes 4 answers25k views
What interval makes sense for repeating ferritin on oral semaglutide?

The case in front of me: ferritin · oral semaglutide. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the…

bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

296 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questions
a1c
a1c

Glycated haemoglobin as a ninety-day glycaemic average: what a change of half a point means, why it lags, and the conditions under which it…

122 questions
oral-glp1
oral-glp1

Oral routes for GLP-1 receptor agonism: peptide formulations rescued by absorption enhancers such as SNAC, and true small molecules that need no…

219 questions
asked by colm_dunphy 8.2k · 2.3 years ago
15 votes0 answers6.7k views
Does the STEP 3 population resemble anyone asking about semaglutide here?

The case in front of me: STEP 3 · semaglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questions
semaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

470 questions
asked by p_mkhize 58k · 2.3 years ago
19 votes 5 answers51k views
What did the placebo arm of REDEFINE-1 report for early satiety?

The particulars: REDEFINE-1 · early satiety. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
gi-side-effects
gi-side-effects

The gastrointestinal cluster as a whole - nausea, vomiting, diarrhoea, constipation, reflux, early satiety - with trial incidence rates, dropout…

162 questions
asked by teodora_ilic 17k · 2.3 years ago
39 votes0 answers49k views
How long does a Wuxi to Finland lane usually take with tracking?

For reference: Wuxi · Finland. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably comfortable with…

international-shipping
international-shipping

Cross-border movement of research material: transit lanes and their thermal profiles, tracked versus untracked, declaration accuracy, and what…

471 questions
customs
customs

Customs handling: how declarations are assessed, why a parcel sits at a facility for a week, seizure notices, and the practical difference between…

196 questions
cold-chain
cold-chain

Keeping material within a temperature window from manufacture to use: phase-change packs versus dry ice, thermal mass, transit-lane temperature…

578 questions
asked by cap_the_luer 14k · 2.3 years ago
37 votes 2 answers47k views
Does potassium tell me anything about hepatic fat on semaglutide?

Conditions: potassium · semaglutide. I understand the observation; what I do not understand is the mechanism behind it. I have read the two review articles that come…

liver-enzymes
liver-enzymes

ALT, AST, GGT and ALP: what they do and do not indicate about hepatic fat, why enzymes are a poor surrogate for histology, and where non-invasive…

91 questions
mash
mash

Metabolic dysfunction-associated steatohepatitis: histological endpoints, resolution without worsening fibrosis, fibrosis improvement by stage,…

56 questions
bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

296 questions
electrolytes
electrolytes

Sodium, potassium and magnesium during reduced intake and GI losses: what the symptoms of a shortfall look like, when a panel is worth drawing,…

72 questions
semaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

470 questions
asked by pieter_maas 14k · 2.3 years ago